Rectus Sheath Block for Analgesia After Gynecological Laparotomy

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Gynecologic Surgical Procedures
Interventions
PROCEDURE

Rectus sheath block

bilateral rectus sheath block under ultrasound guidance using 133 mg liposomal bupivacaine and 20 ml bupivacaine 0.25% per side deposited between the rectus abdomens muscle and the posterior rectus sheath.

PROCEDURE

Thoracic Epidural Analgesia

Low thoracic Epidural Analgesia.

DRUG

Liposomal bupivacaine

133 mg liposomal bupivacaine per side for rectus sheath block

DRUG

Bupivacaine Hydrochloride

20 mL bupivacaine 0.25% per side for rectus sheath block

DRUG

Bupivacaine-Hydromorphone Cassette

Bupivacaine 0.625% with hydromorphone 10 mcg/ml for the epidural solution

Trial Locations (1)

27710

RECRUITING

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER

NCT06575699 - Rectus Sheath Block for Analgesia After Gynecological Laparotomy | Biotech Hunter | Biotech Hunter